Literature DB >> 27778413

Altering Conventional to High Density Spinal Cord Stimulation: An Energy Dose-Response Relationship in Neuropathic Pain Therapy.

Frank Wille1,2, Jennifer S Breel1,2, Eric W P Bakker3, Markus W Hollmann2.   

Abstract

OBJECTIVES: To examine whether converting from conventional Spinal Cord Stimulation (SCS) to High Density (HD) SCS reduces neuropathic pain over a period of 12 months in patients with failed SCS therapy.
METHODS: Retrospective, open label, single center, consecutive case series of 30 neuropathic pain patients (Failed Back Surgery Syndrome [FBSS], Complex Regional Pain Syndrome [CRPS], and polyneuropathy [NP]). Patients with an initial adequate response to conventional SCS, but in whom pain increased over time, were included (Numeric Rating Scales [NRS] >6). These patients were stimulated with HD-SCS parameters and followed-up for 12 months. We report pain intensity, measured with NRS, before SCS implantation, 1 and 3 months after starting SCS with conventional stimulation, and after 1, 6, and 12 months of HD SCS.
RESULTS: Pain reduction with conventional stimulation was initially adequate (NRS mean 8.6 to 5.3 at three months postimplant) but increased over time to a mean NRS of 7.7 at the time of reprogramming. NRS scores decreased significantly to 4.3 (p = 0.015) after reprogramming from conventional SCS (30 Hz, 300 µsec, 3.0 V) to HD SCS (409 Hz, range 130-1000 Hz, 409 µsec, 2.4V) in the patients still using HD-SCS at 12 months. In the nonresponders (patients who stopped HD-SCS for any reason), 76% had a diagnosis of FBSS. Almost half of the patients aborting HD-SCS preferred to feel paresthesias despite better pain relief. There was a significant difference between nonresponders and responders regarding the amount of electrical energy delivered to the spinal cord.
CONCLUSION: Neuropathic pain suppression is significantly enhanced after converting from failed conventional SCS to HD SCS in patients with FBSS, CRPS, and NP over a measured period of 12 months. There appears to be a dose-related response between the amount of energy delivered to the spinal cord and clinical effect.
© 2016 International Neuromodulation Society.

Entities:  

Keywords:  Charge per second; complex regional pain syndrome; failed back surgery syndrome; high density; invasive pain management; neuromodulation; pulse density

Mesh:

Year:  2016        PMID: 27778413     DOI: 10.1111/ner.12529

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  10 in total

Review 1.  Supraspinal Mechanisms of Spinal Cord Stimulation for Modulation of Pain: Five Decades of Research and Prospects for the Future.

Authors:  Eellan Sivanesan; Dermot P Maher; Srinivasa N Raja; Bengt Linderoth; Yun Guan
Journal:  Anesthesiology       Date:  2019-04       Impact factor: 7.892

Review 2.  Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms.

Authors:  Andrei D Sdrulla; Yun Guan; Srinivasa N Raja
Journal:  Pain Pract       Date:  2018-04-23       Impact factor: 3.183

3.  Multicentre, clinical trial of burst spinal cord stimulation for neck and upper limb pain NU-BURST: a trial protocol.

Authors:  Adnan Al-Kaisy; Girish Vajramani; Sarah Love-Jones; Nikunj K Patel; Jonathan Royds; Stefano Palmisani; David Pang; Samuel Wesley; Hyun-Joo Park; Adil Raza; Filippo Agnesi
Journal:  Neurol Sci       Date:  2021-01-02       Impact factor: 3.307

4.  Therapy-Related Explants After Spinal Cord Stimulation: Results of an International Retrospective Chart Review Study.

Authors:  Jean-Pierre Van Buyten; Frank Wille; Iris Smet; Carin Wensing; Jennifer Breel; Edward Karst; Marieke Devos; Katja Pöggel-Krämer; Jan Vesper
Journal:  Neuromodulation       Date:  2017-08-18

5.  Functional magnetic resonance imaging: cerebral function alterations in subthreshold and suprathreshold spinal cord stimulation.

Authors:  Sander De Groote; Mats De Jaeger; Peter Van Schuerbeek; Stefan Sunaert; Ronald Peeters; Dirk Loeckx; Lisa Goudman; Patrice Forget; Ann De Smedt; Maarten Moens
Journal:  J Pain Res       Date:  2018-10-24       Impact factor: 3.133

Review 6.  A scoping review of novel spinal cord stimulation modes for complex regional pain syndrome.

Authors:  Yasmine Hoydonckx; Matteo Costanzi; Anuj Bhatia
Journal:  Can J Pain       Date:  2019-03-05

7.  Real-World Outcomes Using a Spinal Cord Stimulation Device Capable of Combination Therapy for Chronic Pain: A European, Multicenter Experience.

Authors:  Jan Willem Kallewaard; Jose Francisco Paz-Solis; Pasquale De Negri; Maria Angeles Canós-Verdecho; Hayat Belaid; Simon J Thomson; David Abejón; Jan Vesper; Vivek Mehta; Philippe Rigoard; Paolo Maino; Sarah Love-Jones; Isaac F Peña; Simon Bayerl; Christophe Perruchoud; Renaud Bougeard; Cleo Mertz; Yu Pei; Roshini Jain
Journal:  J Clin Med       Date:  2021-09-10       Impact factor: 4.964

8.  Long-Term Efficacy of a Novel Spinal Cord Stimulation Clinical Workflow Using Kilohertz Stimulation: Twelve-Month Results From the Vectors Study.

Authors:  John A Hatheway; Vipul Mangal; Michael A Fishman; Philip Kim; Binit Shah; Rainer Vogel; Vincent Galan; Steven Severyn; Tristan E Weaver; David A Provenzano; Eric Chang; Michael H Verdolin; Gregory Howes; Armando Villarreal; Steven Falowski; Kelly Hendrickson; Katherine Stromberg; Lachlan Davies; Lisa Johanek; Matthew T Kelly
Journal:  Neuromodulation       Date:  2020-12-09

9.  The influence of High Dose Spinal Cord Stimulation on the descending pain modulatory system in patients with failed back surgery syndrome.

Authors:  Sander De Groote; Lisa Goudman; Ronald Peeters; Bengt Linderoth; Peter Van Schuerbeek; Stefan Sunaert; Mats De Jaeger; Ann De Smedt; José De Andrés; Maarten Moens
Journal:  Neuroimage Clin       Date:  2019-11-12       Impact factor: 4.881

10.  Experiences From the Patient Perspective on Spinal Cord Stimulation for Failed Back Surgery Syndrome: A Qualitatively Driven Mixed Method Analysis.

Authors:  Richard L Witkam; Erkan Kurt; Robert van Dongen; Inge Arnts; Monique A H Steegers; Kris C P Vissers; Dylan J H A Henssen; Yvonne Engels
Journal:  Neuromodulation       Date:  2020-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.